Page last updated: 2024-10-24

verapamil and Haemonchiasis

verapamil has been researched along with Haemonchiasis in 2 studies

Verapamil: A calcium channel blocker that is a class IV anti-arrhythmia agent.
verapamil : A racemate comprising equimolar amounts of dexverapamil and (S)-verapamil. An L-type calcium channel blocker of the phenylalkylamine class, it is used (particularly as the hydrochloride salt) in the treatment of hypertension, angina pectoris and cardiac arrhythmia, and as a preventive medication for migraine.
2-(3,4-dimethoxyphenyl)-5-{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino}-2-(propan-2-yl)pentanenitrile : A tertiary amino compound that is 3,4-dimethoxyphenylethylamine in which the hydrogens attached to the nitrogen are replaced by a methyl group and a 4-cyano-4-(3,4-dimethoxyphenyl)-5-methylhexyl group.

Haemonchiasis: Infection with nematodes of the genus HAEMONCHUS, characterized by digestive abnormalities and anemia similar to that from hookworm infestation.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Xu, M1
Molento, M1
Blackhall, W1
Ribeiro, P1
Beech, R1
Prichard, R1
Molento, MB1
Prichard, RK1

Other Studies

2 other studies available for verapamil and Haemonchiasis

ArticleYear
Ivermectin resistance in nematodes may be caused by alteration of P-glycoprotein homolog.
    Molecular and biochemical parasitology, 1998, Mar-15, Volume: 91, Issue:2

    Topics: Amino Acid Sequence; Animals; Anti-Bacterial Agents; Antinematodal Agents; ATP Binding Cassette Tran

1998
Effects of the multidrug-resistance-reversing agents verapamil and CL 347,099 on the efficacy of ivermectin or moxidectin against unselected and drug-selected strains of Haemonchus contortus in jirds (Meriones unguiculatus).
    Parasitology research, 1999, Volume: 85, Issue:12

    Topics: Animals; Anti-Bacterial Agents; Antinematodal Agents; Calcium Channel Blockers; Drug Interactions; D

1999